Literature DB >> 25102472

Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.

Yuan-Pin Hung1, Hsiao-Ju Lin1, Chi-Jung Wu2, Po-Lin Chen3, Jen-Chieh Lee3, Hsiao-Chieh Liu4, Yi-Hui Wu5, Fang Hao Yeh6, Pei-Jane Tsai7, Wen-Chien Ko8.   

Abstract

An 85 year-old male initially admitted for septic shock due to urinary tract infection experienced Clostridium difficile-associated diarrhea during hospitalization and was treated by oral vancomycin. His clinical course was complicated by cytomegalovirus colitis and then vancomycin-resistant Clostridium innocuum bacteremia, which was cured by uneventfully parenteral piperacillin-tazobactam therapy.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile infection; Clostridium innocuum; Cytomegalovirus colitis; Oral vancomycin

Mesh：

Substances：

Year:  2014        PMID： 25102472     DOI： 10.1016/j.anaerobe.2014.07.009

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  5 in total

Review 1.  Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?

Authors:  Alice Gage-Brown; Catherine George; Jenna Maleki; Kasha P Singh; Stephen Muhi
Journal:  Healthcare (Basel)       Date:  2022-05-05

2.  The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.

Authors:  John F Kokai-Kun; Tracey Roberts; Olivia Coughlin; Eric Sicard; Marianne Rufiange; Richard Fedorak; Christian Carter; Marijke H Adams; James Longstreth; Heidi Whalen; Joseph Sliman
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

3.  Case-Control Study of Clostridium innocuum Infection, Taiwan.

Authors:  Yi-Ching Chen; Yi-Chun Kuo; Mi-Chi Chen; Young-Da Zhang; Chyi-Liang Chen; Puo-Hsien Le; Cheng-Hsun Chiu
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

Review 4.  Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen.

Authors:  Kathryn E Cherny; Emily B Muscat; Megan E Reyna; Larry K Kociolek
Journal:  Anaerobe       Date:  2021-07-28       Impact factor: 3.331

5.  Osteomyelitis due to Clostridium innocuum in a patient with acute lymphoblastic leukemia: case report and literature review.

Authors:  Yoshikazu Mutoh; Risen Hirai; Akira Tanimura; Takashi Matono; Eriko Morino; Satoshi Kutsuna; Maki Nagamatsu; Norio Ohmagari; Shotaro Hagiwara
Journal:  Springerplus       Date:  2015-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.